An immunologist's guide to CD31 function in T-cells

Journal of Cell Science

Volumn 126, Issue 11, 2013, Pages 2343-2352

  Marelli Berg, Federica M ^a   Clement, Marc ^b   Mauro, Claudio ^a   Caligiuri, Giuseppina ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b INSERM   (France)

Author keywords

CD31; Cell signaling; MHC; PECAM 1; T lymphocyte; Tolerance; Trafficking

Indexed keywords

CD31 ANTIGEN; PHOSPHATASE;

ARTICLE; CELL ADHESION; CELL FUNCTION; CELL INTERACTION; CELL MIGRATION; CELLULAR IMMUNITY; CYTOPLASM; CYTOTOXICITY; EFFECTOR CELL; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CD31; CELL SIGNALING; MHC; PECAM-1; T-LYMPHOCYTE; TOLERANCE; TRAFFICKING;

ANIMALS; ANTIGENS, CD31; CELL ADHESION; CELL MOVEMENT; HUMANS; IMMUNITY, CELLULAR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84880006585     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.124099     Document Type: Article

References (89)

1. Appleman, L. J. and Boussiotis, V. A. (2003). T cell anergy and costimulation. Immunol. Rev. 192, 161-180.
2. Behar, E., Chao, N. J., Hiraki, D. D., Krishnaswamy, S., Brown, B. W., Zehnder, J. L. and Grumet, F. C. (1996). Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease. N. Engl. J. Med. 334, 286-291.
3. Bergom, C., Gao, C. and Newman, P. J. (2005). Mechanisms of PECAM-1-mediated cytoprotection and implications for cancer cell survival. Leuk. Lymphoma 46, 1409- 1421.
4. Bird, I. N., Spragg, J. H., Ager, A. and Matthews, N. (1993). Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology 80, 553-560.
5. Biswas, P., Canosa, S., Schoenfeld, D., Schoenfeld, J., Li, P., Cheas, L. C., Zhang, J., Cordova, A., Sumpio, B. and Madri, J. A. (2006). PECAM-1 affects GSK-3beta-mediated beta-catenin phosphorylation and degradation. Am. J. Pathol. 169, 314-324.
6. Bogen, S., Pak, J., Garifallou, M., Deng, X. and Muller, W. A. (1994). Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J. Exp. Med. 179, 1059-1064.
7. Boulday, G., Fitau, J., Coupel, S., Soulillou, J. P. and Charreau, B. (2004). Exogenous tissue inhibitor of metalloproteinase-1 promotes endothelial cell survival through activation of the phosphatidylinositol 3-kinase/Akt pathway. Ann. N. Y. Acad. Sci. 1030, 28-36.
8. Brezinschek, R. I., Oppenheimer-Marks, N. and Lipsky, P. E. (1999). Activated T cells acquire endothelial cell surface determinants during transendothelial migration. J. Immunol. 162, 1677-1684.
9. Caligiuri, G., Groyer, E., Khallou-Laschet, J., Al Haj Zen, A., Sainz, J., Urbain, D., Gaston, A. T., Lemitre, M., Nicoletti, A. and Lafont, A. (2005). Reduced immunoregulatory CD31+ T cells in the blood of atherosclerotic mice with plaque thrombosis. Arterioscler. Thromb. Vasc. Biol. 25, 1659-1664.
10. Caligiuri, G., Rossignol, P., Julia, P., Groyer, E., Mouradian, D., Urbain, D., Misra, N., Ollivier, V., Sapoval, M., Boutouyrie, P. et al. (2006). Reduced immunoregulatory CD31+ T cells in patients with atherosclerotic abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 26, 618-623.
11. Chen, Y., Schlegel, P. G., Tran, N., Thompson, D., Zehnder, J. L. and Chao, N. J. (1997). Administration of a CD31-derived peptide delays the onset and significantly increases survival from lethal graft-versus-host disease. Blood 89, 1452- 1459.
12. Darom, A., Gomatos, I. P., Leandros, E., Chatzigianni, E., Panousopoulos, D., Konstadoulakis, M. M. and Androulakis, G. (2006). Molecular markers (PECAM- 1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients. World J. Gastroenterol. 12, 1924-1932.
13. Deaglio, S., Morra, M., Mallone, R., Ausiello, C. M., Prager, E., Garbarino, G., Dianzani, U., Stockinger, H. and Malavasi, F. (1998). Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J. Immunol. 160, 395-402.
14. Decking, J., Mayer, A., Petrow, P., Seiffge, D. and Karbowski, A. (2001). Antibodies to PECAM-1 and glucocorticoids reduce leukocyte adhesion in adjuvant arthritis of the rat knee synovium in vivo. Inflamm. Res. 50, 609-615.
15. Demeure, C. E., Byun, D. G., Yang, L. P., Vezzio, N. and Delespesse, G. (1996). CD31 (PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cells. Immunology 88, 110-115.
16. Diacovo, T. G., Puri, K. D., Warnock, R. A., Springer, T. A. and von Andrian, U. H. (1996). Platelet-mediated lymphocyte delivery to high endothelial venules. Science 273, 252-255.
17. Duncan, G. S., Andrew, D. P., Takimoto, H., Kaufman, S. A., Yoshida, H., Spellberg, J., de la Pompa, J. L., Elia, A., Wakeham, A., Karan-Tamir, B. et al. (1999). Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J. Immunol. 162, 3022-3030.
18. El-Chennawi, F. A., Kamel, H. A., Mosaad, Y. M., El-Sherbini, S. M. and El-Billey, N. A. (2006). Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling. Hematology 11, 227-234.
19. Elrayess, M. A., Webb, K. E., Bellingan, G. J., Whittall, R. A., Kabir, J., Hawe, E., Syvänne, M., Taskinen, M. R., Frick, M. H., Nieminen, M. S. et al. (2004). R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD events. Atherosclerosis 177, 127- 135.
20. Falati, S., Patil, S., Gross, P. L., Stapleton, M., Merrill-Skoloff, G., Barrett, N. E., Pixton, K. L., Weiler, H., Cooley, B., Newman, D. K. et al. (2006). Platelet PECAM-1 inhibits thrombus formation in vivo. Blood 107, 535-541.
21. Fornasa, G., Groyer, E., Clement, M., Dimitrov, J., Compain, C., Gaston, A. T., Varthaman, A., Khallou-Laschet, J., Newman, D. K., Graff-Dubois, S. et al. (2010). TCR stimulation drives cleavage and shedding of the ITIM receptor CD31. J. Immunol. 184, 5485-5492.
22. Fornasa, G., Clement, M., Groyer, E., Gaston, A. T., Khallou-Laschet, J., Morvan, M., Guedj, K., Kaveri, S. V., Tedgui, A., Michel, J. B. et al. (2012). A CD31- derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation. Cardiovasc. Res. 94, 30-37.
23. Goel, R., Boylan, B., Gruman, L., Newman, P. J., North, P. E. and Newman, D. K. (2007). The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G1205-G1214.
24. Goel, R., Schrank, B. R., Arora, S., Boylan, B., Fleming, B., Miura, H., Newman, P. J., Molthen, R. C. and Newman, D. K. (2008). Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 28, 1996-2002.
25. Gomez, I., Hainz, U., Jenewein, B., Schwaiger, S., Wolf, A. M. and Grubeck- Loebenstein, B. (2003). Changes in the expression of CD31 and CXCR3 in CD4+ naïve T cells in elderly persons. Mech. Ageing Dev. 124, 395-402.
26. Goodman, R. S., Kirton, C. M., Oostingh, G. J., Schön, M. P., Clark, M. R., Bradley, J. A. and Taylor, C. J. (2008). PECAM-1 polymorphism affects monocyte adhesion to endothelial cells. Transplantation 85, 471-477.
27. Graesser, D., Solowiej, A., Bruckner, M., Osterweil, E., Juedes, A., Davis, S., Ruddle, N. H., Engelhardt, B. and Madri, J. A. (2002). Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice. J. Clin. Invest. 109, 383-392.
28. Groyer, E., Nicoletti, A., Ait-Oufella, H., Khallou-Laschet, J., Varthaman, A., Gaston, A. T., Thaunat, O., Kaveri, S. V., Blatny, R., Stockinger, H. et al. (2007). Atheroprotective effect of CD31 receptor globulin through enrichment of circulating regulatory T-cells. J. Am. Coll. Cardiol. 50, 344-350.
29. Grumet, F. C., Hiraki, D. D., Brown, B. W. M., Zehnder, J. L., Zacks, E. S., Draksharapu, A., Parnes, J. and Negrin, R. S. (2001). CD31 mismatching affects marrow transplantation outcome. Biol. Blood Marrow Transplant. 7, 503-512.
30. Guntermann, C. and Alexander, D. R. (2002). CTLA-4 suppresses proximal TCR signaling in resting human CD4(+) T cells by inhibiting ZAP-70 Tyr(319) phosphorylation: a potential role for tyrosine phosphatases. J. Immunol. 168, 4420- 4429.
31. Haas, J., Fritzsching, B., Trübswetter, P., Korporal, M., Milkova, L., Fritz, B., Vobis, D., Krammer, P. H., Suri-Payer, E. and Wildemann, B. (2007). Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J. Immunol. 179, 1322-1330.
32. Harry, B. L., Sanders, J. M., Feaver, R. E., Lansey, M., Deem, T. L., Zarbock, A., Bruce, A. C., Pryor, A. W., Gelfand, B. D., Blackman, B. R. et al. (2008). Endothelial cell PECAM-1 promotes atherosclerotic lesions in areas of disturbed flow in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 28, 2003-2008.
33. Henshall, T. L., Jones, K. L., Wilkinson, R. and Jackson, D. E. (2001). Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling. J. Immunol. 166, 3098-3106.
34. Ishikawa, J., Okada, Y., Bird, I. N., Jasani, B., Spragg, J. H. and Yamada, T. (2002). Use of anti-platelet-endothelial cell adhesion molecule-1 antibody in the control of disease progression in established collagen-induced arthritis in DBA/1J mice. Jpn. J. Pharmacol. 88, 332-340.
35. Jenkins, M. K., Khoruts, A., Ingulli, E., Mueller, D. L., McSorley, S. J., Reinhardt, R. L., Itano, A. and Pape, K. A. (2001). In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19, 23-45.
36. Khattab, A. Z., Ahmed, M. I., Fouad, M. A. and Essa, W. A. (2009). Significance of p53 and CD31 in astrogliomas. Med. Oncol. 26, 86-92.
37. Kilpatrick, R. D., Rickabaugh, T., Hultin, L. E., Hultin, P., Hausner, M. A., Detels, R., Phair, J. and Jamieson, B. D. (2008). Homeostasis of the naive CD4+ T cell compartment during aging. J. Immunol. 180, 1499-1507.
38. Kimmig, S., Przybylski, G. K., Schmidt, C. A., Laurisch, K., Möwes, B., Radbruch, A. and Thiel, A. (2002). Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J. Exp. Med. 195, 789-794.
39. Kishore, M., Ma, L., Cornish, G., Nourshargh, S. and Marelli-Berg, F. M. (2012). Primed T cell responses to chemokines are regulated by the immunoglobulin-like molecule CD31. PLoS ONE 7, e39433.
40. Kohler, S. and Thiel, A. (2009). Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. Blood 113, 769-774.
41. Liao, F., Ali, J., Greene, T. and Muller, W. A. (1997). Soluble domain 1 of plateletendothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J. Exp. Med. 185, 1349-1357.
42. Listi, F., Candore, G., Lio, D., Cavallone, L., Colonna-Romano, G., Caruso, M., Hoffmann, E. and Caruso, C. (2004). Association between platelet endothelial cellular adhesion molecule 1 (PECAM-1/CD31) polymorphisms and acute myocardial infarction: a study in patients from Sicily. Eur. J. Immunogenet. 31, 175-178.
43. Listi F., Caruso, C., Balistreri, C. R., Grimaldi, M. P., Caruso, M., Caimi, G., Hoffmann, E., Lio, D. and Candore, G. (2007). PECAM-1/CD31 in infarction and longevity. Ann. N. Y. Acad. Sci. 1100, 132-139.
44. Ma, L., Mauro, C., Cornish, G. H., Chai, J. G., Coe, D., Fu, H., Patton, D., Okkenhaug, K., Franzoso, G., Dyson, J. et al. (2010). Ig gene-like molecule CD31 plays a nonredundant role in the regulation of T-cell immunity and tolerance. Proc. Natl. Acad. Sci. USA 107, 19461-19466.
45. Ma, L., Cheung, K. C., Kishore, M., Nourshargh, S., Mauro, C. and Marelli-Berg, F. M. (2012). CD31 exhibits multiple roles in regulating T lymphocyte trafficking in vivo. J. Immunol. 189, 4104-4111.
46. Maas, M., Stapleton, M., Bergom, C., Mattson, D. L., Newman, D. K. and Newman, P. J. (2005). Endothelial cell PECAM-1 confers protection against endotoxic shock. Am. J. Physiol. Heart Circ. Physiol. 288, H159-H164.
47. Mamdouh, Z., Chen, X., Pierini, L. M., Maxfield, F. R. and Muller, W. A. (2003). Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis. Nature 421, 748-753.
48. Manes, T. D. and Pober, J. S. (2011). Identification of endothelial cell junctional proteins and lymphocyte receptors involved in transendothelial migration of human effector memory CD4+ T cells. J. Immunol. 186, 1763-1768.
49. Manes, T. D., Hoer, S., Muller, W. A., Lehner, P. J. and Pober, J. S. (2010). Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins block distinct steps in transendothelial migration of effector memory CD4+ T cells by targeting different endothelial proteins. J. Immunol. 184, 5186-5192.
50. Marelli-Berg, F. M., Okkenhaug, K. and Mirenda, V. (2007). A two-signal model for T cell trafficking. Trends Immunol. 28, 267-273.
51. Marelli-Berg, F. M., Cannella, L., Dazzi, F. and Mirenda, V. (2008). The highway code of T cell trafficking. J. Pathol. 214, 179-189.
52. Miller, M., Sung, K. L., Muller, W. A., Cho, J. Y., Roman, M., Castaneda, D., Nayar, J., Condon, T., Kim, J., Sriramarao, P. et al. (2001). Eosinophil tissue recruitment to sites of allergic inflammation in the lung is platelet endothelial cell adhesion molecule independent. J. Immunol. 167, 2292-2297.
53. Newman, P. J. (1999). Switched at birth: a new family for PECAM-1. J. Clin. Invest. 103, 5-9.
54. Newman, P. J. and Newman, D. K. (2003). Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler. Thromb. Vasc. Biol. 23, 953-964.
55. Newman, D. K., Hamilton, C. and Newman, P. J. (2001). Inhibition of antigenreceptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Blood 97, 2351-2357.
56. Newton, J. P., Hunter, A. P., Simmons, D. L., Buckley, C. D. and Harvey, D. J. (1999). CD31 (PECAM-1) exists as a dimer and is heavily N-glycosylated. Biochem. Biophys. Res. Commun. 261, 283-291.
57. Newton-Nash, D. K. and Newman, P. J. (1999). A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J. Immunol. 2, 682-688.
58. Nishihara, M., Ogura, H., Ueda, N., Tsuruoka, M., Kitabayashi, C., Tsuji, F., Aono, H., Ishihara, K., Huseby, E., Betz, U. A. et al. (2007). IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Int. Immunol. 19, 695-702.
59. Nourshargh, S. and Marelli-Berg, F. M. (2005). Transmigration through venular walls: a key regulator of leukocyte phenotype and function. Trends Immunol. 26, 157- 165.
60. Novinska, M. S., Pietz, B. C., Ellis, T. M., Newman, D. K. and Newman, P. J. (2006). The alleles of PECAM-1. Gene 376, 95-101.
61. Piali, L., Hammel, P., Uherek, C., Bachmann, F., Gisler, R. H., Dunon, D. and Imhof, B. A. (1995). CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J. Cell Biol. 130, 451-460.
62. Pober, J. S. and Tellides, G. (2012). Participation of blood vessel cells in human adaptive immune responses. Trends Immunol. 33, 49-57.
63. Prager, E., Sunder-Plassmann, R., Hansmann, C., Koch, C., Holter, W., Knapp, W. and Stockinger, H. (1996). Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses. J. Exp. Med. 184, 41- 50.
64. Prager, E., Staffler, G., Majdic, O., Säemann, M., Godár, S., Zlabinger, G. and Stockinger, H. (2001). Induction of hyporesponsiveness and impaired T lymphocyte activation by the CD31 receptor:ligand pathway in T cells. J. Immunol. 166, 2364- 2371.
65. Privratsky, J. R., Newman, D. K. and Newman, P. J. (2010). PECAM-1: conflicts of interest in inflammation. Life Sci. 87, 69-82.
66. Privratsky, J. R., Paddock, C. M., Florey, O., Newman, D. K., Muller, W. A. and Newman, P. J. (2011). Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity. J. Cell Sci. 124, 1477-1485.
67. Qing, Z., Sandor, M., Radvany, Z., Sewell, D., Falus, A., Potthoff, D., Muller, W. A. and Fabry, Z. (2001). Inhibition of antigen-specific T cell trafficking into the central nervous system via blocking PECAM1/CD31 molecule. J. Neuropathol. Exp. Neurol. 60, 798-807.
68. Ravetch, J. V. and Lanier, L. L. (2000). Immune inhibitory receptors. Science 290, 84- 89.
69. Reinke, E. K., Lee, J., Zozulya, A., Karman, J., Muller, W. A., Sandor, M. and Fabry, Z. (2007). Short-term sPECAM-Fc treatment ameliorates EAE while chronic use hastens onset of symptoms. J. Neuroimmunol. 186, 86-93.
70. Roosnek, E. E., Van Lier, R. A. and Aarden, L. A. (1987). Two monoclonal anti-CD3 antibodies can induce different events in human T lymphocyte activation. Eur. J. Immunol. 17, 1507-1510.
71. Ross, E. A., Coughlan, R. E., Flores-Langarica, A., Bobat, S., Marshall, J. L., Hussain, K., Charlesworth, J., Abhyankar, N., Hitchcock, J., Gil, C. et al. (2011). CD31 is required on CD4+ T cells to promote T cell survival during Salmonella infection. J. Immunol. 187, 1553-1565.
72. Rui, Y., Liu, X., Li, N., Jiang, Y., Chen, G., Cao, X. and Wang, J. (2007). PECAM-1 ligation negatively regulates TLR4 signaling in macrophages. J. Immunol. 179, 7344- 7351.
73. Sachs, U. J., Andrei-Selmer, C. L., Maniar, A., Weiss, T., Paddock, C., Orlova, V. V., Choi, E. Y., Newman, P. J., Preissner, K. T., Chavakis, T. et al. (2007). The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). J. Biol. Chem. 282, 23603-23612.
74. Sapino, A., Bongiovanni, M., Cassoni, P., Righi, L., Arisio, R., Deaglio, S. and Malavasi, F. (2001). Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast. J. Pathol. 194, 254-261.
75. Schenkel, A. R., Chew, T. W. and Muller, W. A. (2004). Platelet endothelial cell adhesion molecule deficiency or blockade significantly reduces leukocyte emigration in a majority of mouse strains. J. Immunol. 173, 6403-6408.
76. Semple, J. W., Italiano, J. E., Jr and Freedman, J. (2011). Platelets and the immune continuum. Nat. Rev. Immunol. 11, 264-274.
77. Sobel, R. A., Blanchette, B. W., Bhan, A. K. and Colvin, R. B. (1984). The immunopathology of experimental allergic encephalomyelitis. II. Endothelial cell Ia increases prior to inflammatory cell infiltration. J. Immunol. 132, 2402-2407.
78. Stockinger, H., Schreiber, W., Majdic, O., Holter, W., Maurer, D. and Knapp, W. (1992). Phenotype of human T cells expressing CD31, a molecule of the immunoglobulin supergene family. Immunology 75, 53-58.
79. Tada, Y., Koarada, S., Morito, F., Ushiyama, O., Haruta, Y., Kanegae, F., Ohta, A., Ho, A., Mak, T. W. and Nagasawa, K. (2003). Acceleration of the onset of collageninduced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1. Arthritis Rheum. 48, 3280-3290.
80. Tanaka, Y., Albelda, S. M., Horgan, K. J., van Seventer, G. A., Shimizu, Y., Newman, W., Hallam, J., Newman, P. J., Buck, C. A. and Shaw, S. (1992). CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrinmediated adhesion. J. Exp. Med. 176, 245-253.
81. Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A. and Sharpe, A. H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
82. Torimoto, Y., Rothstein, D. M., Dang, N. H., Schlossman, S. F. and Morimoto, C. (1992). CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation. J. Immunol. 148, 388-396.
83. Vaporciyan, A. A., DeLisser, H. M., Yan, H.-C., Mendiguren, I. I., Thom, S. R., Jones, M. L., Ward, P. A. and Albelda, S. M. (1993). Involvement of plateletendothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science 262, 1580-1582.
84. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H. and Mak, T. W. (1995). Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985-988.
85. Wilkinson, R., Lyons, A. B., Roberts, D., Wong, M. X., Bartley, P. A. and Jackson, D. E. (2002). Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)-mediated activation, and autoimmune disease. Blood 100, 184-193.
86. Wing, K. and Sakaguchi, S. (2010). Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11, 7-13.
87. Wong, M. X., Hayball, J. D., Hogarth, P. M. and Jackson, D. E. (2005). The inhibitory co-receptor, PECAM-1 provides a protective effect in suppression of collagen-induced arthritis. J. Clin. Immunol. 25, 19-28.
88. Wu, Y., Tworkoski, K., Michaud, M. and Madri, J. A. (2009). Bone marrow monocyte PECAM-1 deficiency elicits increased osteoclastogenesis resulting in trabecular bone loss. J. Immunol. 182, 2672-2679.
89. Zhao, T. and Newman, P. J. (2001). Integrin activation by regulated dimerization and oligomerization of platelet endothelial cell adhesion molecule (PECAM)-1 from within the cell. J. Cell Biol. 152, 65-73.